Martin VanTrieste Leads the Way at Civica Rx
May 21, 2020
He was reluctant to take the CEO job, but VanTrieste has the unique nonprofit drug manufacturer surpassing its goals and possibly branching out into the retail market.
Keith Loria
11 Trends Influencing Biosimilars in 2020
May 18, 2020
The purpose of biosimilar is simple: reduce healthcare costs, pure and simple. Here are 11 trends affecting biosimilars over the last year in the U.S.
Health Execs: Here are 5 Important Takeaways About the Current Situation With Biosimilars
May 18, 2020
Just as we’ve seen the entire healthcare landscape change in 2020 because of COVID-19, the world of biosimilars is ever-changing.
In Harm’s Way: Nursing Homes in the COVID-19 Pandemic
May 18, 2020
Residents and staff have been hit hard by the disease. PPE is in short supply. The deaths are taking an emotional toll on largely unheralded workers.
Proving Biosimilars are Similar. Are Therapeutic Trials Necessary?
May 4, 2020
Cecil Nick, vice president of biotechnology at Parexel International,
Understanding Biosimilar Approvals
May 1, 2020
Why are so few biosimilars approved and on the market in the U.S.?
Patients in Observation Status
April 20, 2020
How are healthcare systems addressing the shift from inpatient to observation?
Satisfying Patient Needs Across the Generations
April 18, 2020
How to appeal to people of any age.
Top 8 Healthcare Business Trends
April 15, 2020
Healthcare executives and consultants told us which strategic trends to look out for — before COVID-19.
Basu Takes the Reins at CTCA
April 14, 2020
As president and CEO of Cancer Treatment Centers of America, Pat A. Basu, MD, MBA, looks to transform, improve, and influence cancer care on a large scale.
